Fetal Supraventricular Tachycardia and Maternal COVID-19 Vaccination: is There Any relationship?

Abdallah, Wael; Rechdan, Johnny B.; Lakkis, Razane; Nassar, M.; Daou, Linda; Kassis, Nadine El; Atallah, David

doi:10.2144/fsoa-2022-0007

Cited by 6 publications

(1 citation statement)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A report of supraventricular tachycardia (SVT) that occurred after ChAdOx1 nCoV-19 vaccine inoculation explained that the fever generated after vaccination caused vasodilation and hypotension and that an increase in heart rate to increase cardiac output might have led to SVT[6]. Abdallah et al have published a report of two cases of fetal supraventricular tachycardia occurring after maternal BNT162b2 vaccination[12]. The report suggests that immune transfer through the placenta and potential impact of the immune response might be linked to SVT, although the exact cause is still unclear.Our patient presented with SVT at two days after COVID-19 mRNA vaccination.…”

mentioning

confidence: 99%

Paroxysmal supraventricular tachycardia after messenger RNA COVID-19 vaccine in previously healthy adolescent: a case report

Rho,

Cho

2024

Med Biol Sci Eng

View full text Add to dashboard Cite

Coronavirus infectious disease 2019 infection in children and adolescents causes mild symptoms, but some may require hospitalization or Intensive care unit treatment. Therefore, the importance of vaccinating children and adolescents against COVID-19 is emphasized. However, various side effects related to the heart after COVID-19 mRNA vaccination have been reported. In one study, 227 out of 243 patients were diagnosed with myocarditis, 7 with pericarditis, and 4 with Takotsubo cardiomyopathy. One case report showed paroxysmal tachycardia developed after receiving the AstraZeneca COVID-19 vaccine in a male with previous history of paroxysmal tachycardia. In this report, we present a case of paroxysmal tachycardia after second dose of Pfizer COVID-19 vaccine without any previous history of cardiac problems. The cardiovascular complications as a side effect of COVID-19 vaccination are rare but can be fatal. Therefore, it is necessary to remain vigilant and monitor adverse reactions that may occur with the COVID-19 vaccine.

show abstract

mentioning

confidence: 99%

Paroxysmal supraventricular tachycardia after messenger RNA COVID-19 vaccine in previously healthy adolescent: a case report

Rho,

Cho

2024

Med Biol Sci Eng

View full text Add to dashboard Cite

show abstract

Incidence of Fetal Arrhythmia Before and During the COVID-19 Pandemic: A Single-Center Experience

Samples,

Patel,

Lee

et al. 2024

Pediatr Cardiol

View full text Add to dashboard Cite

Background: Fetal arrhythmias are rare and carry signi cant morbidity and mortality without appropriate treatment. Initial reports exist of fetal arrhythmia in the setting of maternal COVID-19 infection. Our study sought to evaluate incidence of fetal arrhythmia before and during the COVID-19 pandemic at our institution.Methods: This retrospective cohort study from a tertiary care fetal cardiac center utilized the institutional REDCap database to search fetal arrhythmia diagnostic codes. Medical records of mother-fetus dyads were reviewed and data was collected on diagnoses, gestational age, treatment regimen, and postnatal outcomes. Patients were divided into pre-COVID and peri-COVID segments.Results: 8368 total pregnancies were evaluated during the 7.3 years of study period. 45 patients (0.5%) had a signi cant fetal arrhythmia and were included in this study: 19 (42%) in the pre-COVID-19 group and 26 (58%) in the peri-COVID-19 group. No patients had associated congenital heart disease. There was a notable increase in the incidence of fetal supraventricular tachycardia (1.82 per 1000 vs 2.65 per 1000 pregnancies) and complete heart block (1.04 per 1000 vs 1.77 per 1000 pregnancies) but no apparent change in other tachyarrhythmias during the COVID era. The proportion of antibody-mediated complete heart block increased from 50% to 87.5%. There was also an increase in the percentage of supraventricular tachycardia patients requiring postnatal treatment during COVID-19 (53.8% vs 62.5%).Conclusions: Our experience shows an increased incidence of some fetal arrhythmia diagnoses during the COVID-19 pandemic. Additional multi-center studies will be necessary to fully evaluate the increased burden of fetal arrhythmias during the COVID-19 era as well as to elucidate etiology.

show abstract

Tozinameran

2023

Reactions Weekly

View full text Add to dashboard Cite

Fetal Supraventricular Tachycardia and Maternal COVID-19 Vaccination: is There Any relationship?

Cited by 6 publications

References 11 publications

Paroxysmal supraventricular tachycardia after messenger RNA COVID-19 vaccine in previously healthy adolescent: a case report

Paroxysmal supraventricular tachycardia after messenger RNA COVID-19 vaccine in previously healthy adolescent: a case report

Incidence of Fetal Arrhythmia Before and During the COVID-19 Pandemic: A Single-Center Experience

Tozinameran

Contact Info

Product

Resources

About